9KJ9
Anti-CRISPR protein AcrVIA6
Summary for 9KJ9
| Entry DOI | 10.2210/pdb9kj9/pdb |
| Descriptor | Anti-CRISPR protein (2 entities in total) |
| Functional Keywords | acrvia6, immune system, dna binding protein, structural protein |
| Biological source | Rhodobacter capsulatus |
| Total number of polymer chains | 1 |
| Total formula weight | 10599.12 |
| Authors | |
| Primary citation | Han, J.H.,Lee, S.Y.,Park, H.H. AcrVIA6 Is a Monomeric DNA-Binding Protein That Does Not Directly Inhibit Cas13a. Faseb J., 39:e70753-e70753, 2025 Cited by PubMed Abstract: The CRISPR-Cas system is a crucial adaptive immune mechanism in prokaryotes, providing defense against invading genetic elements. Among various CRISPR-Cas systems, the type VI-A system, employing RNA-guided RNase Cas13a, has been extensively studied for its ability to target and degrade single-stranded RNA. Anti-CRISPR (Acr) proteins have evolved as natural inhibitors of these systems, with AcrVIA proteins specifically targeting the Cas13a enzyme. However, there is currently conflicting debate regarding the anti-CRISPR function of AcrVIA6. This study reveals that AcrVIA6 functions as a DNA-binding protein rather than a Cas13a inhibitor, as it does not block RNA cleavage. These findings challenge its role in CRISPR-Cas regulation. PubMed: 40540289DOI: 10.1096/fj.202500684R PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.39 Å) |
Structure validation
Download full validation report






